Ricardo Geada – Irwin Mitchell

Ricardo Geada is a regulatory partner advising UK and international businesses on compliance, investigations and market access, with a particular focus on the legal cannabis sector (medical and CBD wellness), vaping and other consumer products. I also have worked on matters pertaining to crypto/digital assets.

Ricardos centres on designing compliant routes to market, navigating regulator scrutiny, and managing risk across the UK, EU and multi‑jurisdictional projects.

Before joining Irwin Mitchell, Ricardo led the Regulatory Solutions team at Lawrence Stephens, acting for global cannabis companies and advising on the legality and labelling of e‑cigarettes/e‑liquids, cosmetics, foods and supplements, as well as Home Office licensing for controlled drugs and cultivation.

Ricardos public commentary includes articles in The Times on disposable‑vape policy and the legitimate use cases for crypto. He regularly speaks and moderates at cannabis industry conferences both here and abroad.

Awards

• Legal Week Innovation Awards 2020 – Winner of Marketing Innovation within the Cannabis Industry
• Law Society Excellence Awards 2019 – Shortlisted
• Global Law Experts 2021 – Medical Cannabis Law Team
• Proactive – UK Medical Cannabis Market
• Webinar – CBD Explored – Everything Clinicians need to know about cannabinoid
• Cancard Uncovered – Volteface

Recent Work

• Some of the Regulations covered: Misuse of Drugs Act 1971, Misuse of Drugs Regulations 2001, Consumer Products and Unfair Trading Regulations 2008, Human Medicines Regulations 2012 (guidance given by the UK Regulator – Medicines & Health products Regulatory Agency (“MHRA”), EU Cosmetics Regulations (EC – No. 1223/2009), The Tobacco and Related Products Regulations 2016 (including the Tobacco Products Directive) and General Product Safety Regulations 2005.
• Advising and assisting clients with their CBD Novel Foods Applications (NFA) and/or linked NFA with the Food Standards Agency.
• Conducting marking reviews of client’s CBD product lines and websites making sure they adhere to relevant regulations depending on the type of product in question.
• Review and advising clients in relation to certificates of analysis (CoAs) in respect of the levels of THC contained within the specified product, ensuring such levels are within the permitted amounts as set out by the laws and regulations of those countries the client intends to export to.
• Advising clients in respect of product seizures by boarder force agencies. Successfully getting products released and also obtaining damages for a client where their product line had been destroyed by UK Border Force.
• Advising clients in respect of Controlled Drug Licence.
• Advising clients in respect of Industrial Hemp Cultivation applications in the UK and assisting with the applications process.

Publications, Panel Discussions and Social Media

• ‘New Vaping Laws risk stifling non-nicotine products too’ – Ricardo explores the ban in The Times.
• ‘What’s your why? “I had no interest in cannabis, but the story needed to be told to others like me” – The Maple Tree Consultants.
• Contributing Editor – Chambers & Partners Global Practice Guide: Medical Cannabis & Cannabinoid Regulation
• Joint collaboration with Maple Tree and Mackrell Solicitors: UK Medical Cannabis & CBD Market – Discussion Paper – Ten Recommendations For Government
• InterTabac / CB Expo panel discussion September 2023: Tobacco & Cannabis – Intersecting Journeys and shared lessons / Spotify
• ICBC Berlin April 2024 – panel discussion: EU Novel Foods Update / YouTube
• Joint collaboration with SW4 Partners, Artemis Growth Partners and Lawrence Stephens: Extracting Opportunities – Thought leadership paper – a guide to the thriving European Medical Cannabis Extract Market 2024.
• EVO NXT Malaga April 2024 – panel discussion: Regulation of Cannabis in Europe – Update and Outlook, Risk and Chances